Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Colorcon
US Army
Farmers Insurance
Teva
McKinsey
Cipla
Harvard Business School
Fuji

Generated: February 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TESTIM

« Back to Dashboard

Clinical Trials for Testim

Trial ID Title Status Sponsor Phase Summary
NCT00156650 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1/Phase 2 This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen.
NCT00156650 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum Completed University of Washington Phase 1/Phase 2 This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen.
NCT00161447 Male Hormonal Contraceptive Development-ACY-5 Completed CONRAD Phase 1/Phase 2 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161447 Male Hormonal Contraceptive Development-ACY-5 Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1/Phase 2 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161447 Male Hormonal Contraceptive Development-ACY-5 Completed University of Washington Phase 1/Phase 2 The purpose of this research study is to help in the development of male contraception (birth control).
NCT00161486 The Effects of Testosterone on Prostate Tissue (ACYP-1) Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1 The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
NCT00161486 The Effects of Testosterone on Prostate Tissue (ACYP-1) Completed University of Washington Phase 1 The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Testim

Condition Name

Condition Name for Testim
Intervention Trials
Hypogonadism 6
Contraception 4
Secondary Hypogonadism 2
Metabolic Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Testim
Intervention Trials
Hypogonadism 8
Neoplasm Metastasis 2
Erectile Dysfunction 1
Metabolic Syndrome X 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Testim

Trials by Country

Trials by Country for Testim
Location Trials
United States 17
Denmark 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Testim
Location Trials
Washington 7
Texas 3
California 3
Nevada 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Testim

Clinical Trial Phase

Clinical Trial Phase for Testim
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 2 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Testim
Clinical Trial Phase Trials
Completed 10
Terminated 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Testim

Sponsor Name

Sponsor Name for Testim
Sponsor Trials
University of Washington 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6
Repros Therapeutics Inc. 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Testim
Sponsor Trials
Other 11
Industry 6
NIH 6
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Baxter
McKinsey
Julphar
Express Scripts
Moodys
Cantor Fitzgerald
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.